Mambog (Hibiscus tiliaceus)
Mambog (Hibiscus tiliaceus) is a Polynesian medicinal plant containing bioactive compounds that enhance immune function and provide analgesic effects. The methanolic extracts modulate humoral and cellular immunity while ethanolic extracts demonstrate significant pain inhibition in preclinical studies.

Origin & History
Mambog (Hibiscus tiliaceus) is a coastal evergreen tree from the Malvaceae family, native to tropical regions including Southeast Asia, Indo-China, Papua New Guinea, and Pacific islands. Medicinal extracts are prepared from leaves, flowers, bark, and roots using methanolic, ethanolic, or aqueous methods. The plant contains polyphenols, flavonoids, tannins, alkaloids, and phytosterols.
Historical & Cultural Context
Mambog has been used for centuries across Southeast Asian traditional medicine systems in Indonesia, Amboina, Pahang, Indo-China, and Papua New Guinea. Traditional applications include flowers for birth control and skin infections, leaves as poultices for respiratory issues and wounds, and bark/root preparations as diuretics and laxatives.
Health Benefits
• Immunomodulation: Methanolic leaf extract enhanced humoral and cellular immunity in immunosuppressed rats (preclinical evidence only) • Pain relief: Ethanolic extracts showed 40.5% (leaf) and 52.07% (bark) writhing inhibition in mice at 500mg/kg (preliminary animal data) • Antisickling effects: Aqueous leaf extract demonstrated benefits in sickle cell disease models via kaempferol 3-O-rutinoside and rutin (in vitro evidence) • Ulcer protection: Fresh leaf extracts reduced ulcer lesion index in stress-induced rat models (animal studies only) • Antioxidant activity: Flower extracts showed free radical scavenging properties attributed to vitamins and phytosterols (laboratory testing)
How It Works
Mambog's immunomodulatory effects occur through enhancement of both humoral antibody production and cellular immune responses via methanolic leaf compounds. The analgesic mechanism involves inhibition of pain pathways, with ethanolic bark extracts showing 52.07% writhing inhibition compared to 40.5% for leaf extracts. Additional antisickling activity suggests interaction with hemoglobin polymerization pathways.
Scientific Research
No human clinical trials, RCTs, or meta-analyses have been conducted on Mambog. All evidence comes from preclinical studies in animals or laboratory models, including immunomodulation in Wistar rats, analgesia studies in mice (n=4 per group, PMC4967069), and in vitro antisickling assays. Human safety and efficacy remain unestablished.
Clinical Summary
Current evidence for mambog is limited to preclinical animal studies. Immunomodulation research used immunosuppressed rats treated with methanolic leaf extracts, showing enhanced immune parameters. Pain relief studies in mice demonstrated dose-dependent analgesic effects at 500mg/kg, with bark extracts outperforming leaf extracts. No human clinical trials have been conducted to validate these preliminary findings or establish safe effective dosages.
Nutritional Profile
{"macronutrients": {"fiber": "Approximately 3.5g per 100g of leaves", "protein": "Approximately 2.1g per 100g of leaves"}, "micronutrients": {"vitamins": {"vitamin_C": "Approximately 25mg per 100g of leaves", "vitamin_A": "Approximately 200 IU per 100g of leaves"}, "minerals": {"calcium": "Approximately 150mg per 100g of leaves", "iron": "Approximately 2.3mg per 100g of leaves"}}, "bioactive_compounds": {"kaempferol_3-O-rutinoside": "Present, specific concentration not quantified", "quercetin": "Present, specific concentration not quantified"}, "bioavailability_notes": "The bioavailability of kaempferol and quercetin may be influenced by the presence of dietary fats and the method of preparation. Cooking can reduce vitamin C content significantly."}
Preparation & Dosage
No clinically studied human dosages exist. Animal studies used: 500 mg/kg oral ethanolic extract for pain relief in mice; dose-dependent methanolic extract for immunomodulation in rats; fresh leaf extracts for ulcer protection. Consult a healthcare provider before starting any new supplement.
Synergy & Pairings
Quercetin, Rutin, Green Tea Extract, Vitamin C, Turmeric
Safety & Interactions
Safety data for mambog supplementation is extremely limited due to lack of human studies. Potential interactions with immunosuppressive medications should be considered given the immunomodulatory effects observed in animal research. Pregnancy and breastfeeding safety is unknown and use should be avoided during these periods. Individuals with autoimmune conditions should consult healthcare providers before use due to immune-enhancing properties.